Resumen de acción TORNTPHARM
Torrent Pharmaceuticals Limited se dedica a la investigación, desarrollo, fabricación y comercialización de formulaciones farmacéuticas genéricas en India, Estados Unidos, Brasil, Alemania y a escala internacional. Saber más
| Puntuación del snowflake | |
|---|---|
| Valoración | 0/6 |
| Crecimiento futuro | 5/6 |
| Rendimiento pasado | 6/6 |
| Salud financiera | 6/6 |
| Dividendos | 4/6 |
Competidores de Torrent Pharmaceuticals Limited
Historial de precios y rendimiento
| Precios históricos de las acciones | |
|---|---|
| Precio actual de la acción | ₹3,202.95 |
| Máximo en las últimas 52 semanas | ₹3,590.70 |
| Mínimo de 52 semanas | ₹2,025.70 |
| Beta | 0.26 |
| 1Cambio en 1 mes | -0.39% |
| Variación en 3 meses | -8.10% |
| Cambio de 1 año | 50.62% |
| 3Variación en 3 años | 115.60% |
| Variación en 5 años | 241.84% |
| Variación desde la OPV | 26,591.25% |
Noticias y actualizaciones recientes
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts
Oct 29
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing
Oct 24Recent updates
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts
Oct 29Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing
Oct 24Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets
Jul 26Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark
Apr 16Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 03Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00
Feb 05Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings
Jan 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly
Nov 14Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jun 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Mar 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 25Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture
Jun 02Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
May 25A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Feb 18Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00
Jan 27Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly
Jan 04Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock
Dec 14A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Nov 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Sep 30Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?
Sep 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 02I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease
Jun 01Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate
May 14Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 23Rentabilidad de los accionistas
| TORNTPHARM | IN Pharmaceuticals | Mercado IN | |
|---|---|---|---|
| 7D | 3.3% | 0.8% | 2.9% |
| 1Y | 50.6% | 42.1% | 28.9% |
Rentabilidad vs. Industria: TORNTPHARM superó a la industria Indian Pharmaceuticals, que obtuvo un rendimiento del 42.1% el año pasado.
Rentabilidad vs. Mercado: TORNTPHARM superó al mercado Indian, que obtuvo un rendimiento del 28.9% el año pasado.
Volatilidad de los precios
| TORNTPHARM volatility | |
|---|---|
| TORNTPHARM Average Weekly Movement | 3.6% |
| Pharmaceuticals Industry Average Movement | 6.0% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.0% |
| 10% least volatile stocks in IN Market | 4.0% |
Precio estable de las acciones: TORNTPHARM no ha tenido una volatilidad de precios significativa en los últimos 3 meses.
Volatilidad a lo largo del tiempo: La volatilidad semanal de TORNTPHARM (4%) se ha mantenido estable durante el año pasado.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 1959 | 15,718 | Samir Mehta | www.torrentpharma.com |
Torrent Pharmaceuticals Limited se dedica a la investigación, desarrollo, fabricación y comercialización de formulaciones farmacéuticas genéricas en India, Estados Unidos, Brasil, Alemania y a escala internacional. La empresa ofrece productos en diversas áreas terapéuticas, como cardiovascular, sistema nervioso central, gastrointestinal y salud de la mujer; y dermatología, diabetología, tratamiento del dolor, ginecología, oncología y antiinfecciosos, así como vitaminas, minerales y nutrientes. También ofrece servicios de fabricación por contrato.
Resumen de fundamentos de Torrent Pharmaceuticals Limited
| Estadísticas fundamentales de TORNTPHARM | |
|---|---|
| Capitalización bursátil | ₹1.08t |
| Beneficios(TTM) | ₹18.02b |
| Ingresos (TTM) | ₹112.24b |
60.2x
Ratio precio-beneficio (PE)9.7x
Ratio precio-ventas (PS)¿Está TORNTPHARM sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de TORNTPHARM | |
|---|---|
| Ingresos | ₹112.24b |
| Coste de los ingresos | ₹27.48b |
| Beneficio bruto | ₹84.76b |
| Otros gastos | ₹66.73b |
| Beneficios | ₹18.02b |
Últimos beneficios comunicados
Sep 30, 2024
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | 53.25 |
| Margen bruto | 75.51% |
| Margen de beneficio neto | 16.06% |
| Ratio deuda/patrimonio | 40.6% |
¿Cómo se ha desempeñado TORNTPHARM a largo plazo?
Ver rendimiento histórico y comparativa